These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 38868069)
1. Stem cell index-based RiskScore model for predicting prognosis in thyroid cancer and experimental verification. Chen R; Gao W; Liang L; Yu H; Song W Heliyon; 2024 Jun; 10(11):e31970. PubMed ID: 38868069 [TBL] [Abstract][Full Text] [Related]
2. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma. Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X PeerJ; 2023; 11():e16477. PubMed ID: 38025763 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies. Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J Front Immunol; 2024; 15():1244392. PubMed ID: 38694506 [TBL] [Abstract][Full Text] [Related]
4. Identification of Novel Stemness-based Subtypes and Construction of a Prognostic Risk Model for Patients with Lung Squamous Cell Carcinoma. Shen F; Li F; Ma Y; Song X; Guo W Curr Stem Cell Res Ther; 2024; 19(3):400-416. PubMed ID: 37455452 [TBL] [Abstract][Full Text] [Related]
5. Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma. Li Z; Jin C; Lu X; Zhang Y; Zhang Y; Wen J; Liu Y; Liu X; Li J Ann Transl Med; 2023 Jan; 11(2):61. PubMed ID: 36819514 [TBL] [Abstract][Full Text] [Related]
6. The Identification of Three Key Genes Related to Stemness in Thyroid Carcinoma through Comprehensive Analysis. Zhang T; Yan C; Ye Z; Yin X; Jiang TA Comb Chem High Throughput Screen; 2021; 24(3):423-432. PubMed ID: 32767928 [TBL] [Abstract][Full Text] [Related]
7. Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity. Dai Q; Zhu J; Yang J; Zhang CY; Yang WJ; Pan BS; Yang XR; Guo W; Wang BL Curr Stem Cell Res Ther; 2024 Mar; ():. PubMed ID: 38561604 [TBL] [Abstract][Full Text] [Related]
8. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Xu Q; Xu H; Chen S; Huang W Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040 [No Abstract] [Full Text] [Related]
9. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer. Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627 [TBL] [Abstract][Full Text] [Related]
10. Exploring the role of tumor stemness and the potential of stemness-related risk model in the prognosis of intrahepatic cholangiocarcinoma. Yue Y; Tao J; An D; Shi L Front Genet; 2022; 13():1089405. PubMed ID: 36712866 [No Abstract] [Full Text] [Related]
11. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy. Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y Front Immunol; 2023; 14():1128390. PubMed ID: 36761753 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma. Tian X; Zheng J; Mou W; Lu G; Chen S; Du J; Zheng Y; Chen S; Shen B; Li J; Wang N Front Pharmacol; 2022; 13():939542. PubMed ID: 35935823 [No Abstract] [Full Text] [Related]
13. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses. Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183 [TBL] [Abstract][Full Text] [Related]
14. Characterization of Cancer Stem Cell Characteristics and Development of a Prognostic Stemness Index Cell-Related Signature in Oral Squamous Cell Carcinoma. Feng J; Li Y; Wen N Dis Markers; 2021; 2021():1571421. PubMed ID: 34840626 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma. Zhang M; Wang X; Chen X; Guo F; Hong J Front Genet; 2020; 11():441. PubMed ID: 32431729 [TBL] [Abstract][Full Text] [Related]
16. A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma. Xu H; Zou R; Liu J; Zhu L J Oncol; 2021; 2021():6653247. PubMed ID: 33747079 [TBL] [Abstract][Full Text] [Related]
17. Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma. Lai J; Lin X; Zheng H; Xie B; Fu D BMC Cancer; 2023 Jun; 23(1):525. PubMed ID: 37291533 [TBL] [Abstract][Full Text] [Related]
18. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889 [TBL] [Abstract][Full Text] [Related]
19. mRNAsi-related genes can effectively distinguish hepatocellular carcinoma into new molecular subtypes. Wang C; Qin S; Pan W; Shi X; Gao H; Jin P; Xia X; Ma F Comput Struct Biotechnol J; 2022; 20():2928-2941. PubMed ID: 35765647 [TBL] [Abstract][Full Text] [Related]
20. Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cells. Jin Z; Han Y; Zhang J; Liu Z; Li R; Liu Z J Gene Med; 2024 Jan; 26(1):e3657. PubMed ID: 38282150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]